Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

337.00p
   
  • Change Today:
      14.00p
  • 52 Week High: 340.00
  • 52 Week Low: 147.50
  • Currency: UK Pounds
  • Shares Issued: 46.97m
  • Volume: 115,147
  • Market Cap: £158.28m
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
86.25% below the market average86.25% below the market average86.25% below the market average86.25% below the market average86.25% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
1yr Revenue Growth
24.84% above the market average24.84% above the market average24.84% above the market average24.84% above the market average24.84% above the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
3.48% below the market average3.48% below the market average3.48% below the market average3.48% below the market average3.48% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average
Price Book Ratio
80.57% below the market average80.57% below the market average80.57% below the market average80.57% below the market average80.57% below the market average
29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
71.00% above the market average71.00% above the market average71.00% above the market average71.00% above the market average71.00% above the market average
53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average
Price Chg 3m
94.44% above the market average94.44% above the market average94.44% above the market average94.44% above the market average94.44% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
92.97% above the market average92.97% above the market average92.97% above the market average92.97% above the market average92.97% above the market average
89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average
Momentum 20
87.33% above the market average87.33% above the market average87.33% above the market average87.33% above the market average87.33% above the market average
75.86% above the sector average75.86% above the sector average75.86% above the sector average75.86% above the sector average75.86% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
57.98% below the market average57.98% below the market average57.98% below the market average57.98% below the market average57.98% below the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
12.77% below the market average12.77% below the market average12.77% below the market average12.77% below the market average12.77% below the market average
49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average
Forecast EPS
26.34% below the market average26.34% below the market average26.34% below the market average26.34% below the market average26.34% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
12.48% above the market average12.48% above the market average12.48% above the market average12.48% above the market average12.48% above the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Operating Profit Loss
84.52% below the market average84.52% below the market average84.52% below the market average84.52% below the market average84.52% below the market average
42.37% below the sector average42.37% below the sector average42.37% below the sector average42.37% below the sector average42.37% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
2.82% above the market average2.82% above the market average2.82% above the market average2.82% above the market average2.82% above the market average
13.79% above the sector average13.79% above the sector average13.79% above the sector average13.79% above the sector average13.79% above the sector average
Cash
17.57% below the market average17.57% below the market average17.57% below the market average17.57% below the market average17.57% below the market average
27.59% below the sector average27.59% below the sector average27.59% below the sector average27.59% below the sector average27.59% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
98.04% below the market average98.04% below the market average98.04% below the market average98.04% below the market average98.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Buys 1y
81.82% above the market average81.82% above the market average81.82% above the market average81.82% above the market average81.82% above the market average
62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
39.42% above the market average39.42% above the market average39.42% above the market average39.42% above the market average39.42% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 337.00p
Change Today 14.00p
% Change 4.33 %
52 Week High 340.00
52 Week Low 147.50
Volume 115,147
Shares Issued 46.97m
Market Cap £158.28m
Beta 0.00

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.53% below the market average40.53% below the market average40.53% below the market average40.53% below the market average40.53% below the market average
32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average32.20% above the sector average
Price Trend
98.11% above the market average98.11% above the market average98.11% above the market average98.11% above the market average98.11% above the market average
93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average
Income Not Available
Growth
42.3% below the market average42.3% below the market average42.3% below the market average42.3% below the market average42.3% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 23-Aug-2019

Time Volume / Share Price
16:32 10,000 @ 333.00p
11:53 40,000 @ 328.00p
17:06 200 @ 337.00p
16:29 2,000 @ 340.00p
16:10 1,000 @ 333.00p

Ergomed Key Personnel

COO Jan Petracek

Top of Page